PACS Group (NYSE:PACS) CEO Sells 1,620 Shares of Stock

Key Points

• PACS Group CEO Jason Murray sold 1,620 shares at an average price of $47.57, generating $77,063.40. The transaction was conducted under a pre-arranged Rule 10b5-1 plan, and he still directly owns approximately 54.3 million shares.
• Murray has made several additional stock sales in October, including 110,035 shares on October 15 and 37,477 shares on October 20, reflecting a broader pattern of insider selling.
• PACS shares traded at $46.69, while analysts maintained a generally positive outlook: five analysts rate the stock Buy and two rate it Hold, producing a consensus rating of Moderate Buy and an average price target of $58.80.

PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 1,620 shares of the company's stock in a transaction that occurred on Monday, October 19th. The stock was sold at an average price of $47.57, for a total transaction of $77,063.40. Following the sale, the chief executive officer directly owned 54,314,900 shares in the company, valued at $2,583,759,793. This trade represents a 0.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total transaction of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total transaction of $1,785,779.05.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total transaction of $402,875.82.
• On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total transaction of $5,201,354.45.
• On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The shares were sold at an average price of $45.00, for a total transaction of $10,440.00.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total transaction of $30,458.16.
• On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The stock was sold at an average price of $43.09, for a total transaction of $1,550,162.75.
• On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total value of $1,033,395.84.
• On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The stock was sold at an average price of $42.51, for a total value of $1,107,470.52.
• On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The shares were sold at an average price of $41.13, for a total value of $1,358,606.16.

PACS Group Price Performance

NYSE:PACS traded down $1.03 during trading hours on Wednesday, hitting $46.69. 648,381 shares of the company's stock traded hands, compared to its average volume of 892,400. PACS Group, Inc. has a 52 week low of $10.31 and a 52 week high of $49.49. The business's fifty day simple moving average is $43.58 and its two-hundred day simple moving average is $40.70. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm has a market cap of $7.39 billion, a P/E ratio of 27.14, a P/E/G ratio of 1.43 and a beta of -0.08.

PACS Group (NYSE:PACS - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.54 by $0.09. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. On average, research analysts anticipate that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on PACS shares. Weiss Ratings raised PACS Group from a "hold (c)" rating to a "hold (c+)" rating in a report on Thursday, October 8th. JPMorgan Chase & Co. raised their target price on shares of PACS Group from $47.00 to $58.00 and gave the company an "overweight" rating in a research note on Friday, September 4th. Oppenheimer raised their target price on shares of PACS Group from $48.00 to $57.00 and gave the company an "outperform" rating in a research note on Monday, August 10th. Wall Street Zen lowered shares of PACS Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 8th. Finally, Truist Financial set a $62.00 price target on shares of PACS Group in a research note on Wednesday, September 2nd. Five equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, PACS Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $58.80.

Hedge Funds Weigh In On PACS Group

Several institutional investors have recently modified their holdings of PACS. Dimensional Fund Advisors LP raised its holdings in shares of PACS Group by 370.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company's stock valued at $25,051,000 after buying an additional 614,250 shares in the last quarter. Sei Investments Co. lifted its position in PACS Group by 7.4% in the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company's stock worth $11,900,000 after buying an additional 25,462 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in PACS Group by 44.6% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company's stock worth $9,274,000 after buying an additional 89,067 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in PACS Group in the 2nd quarter worth approximately $8,196,000. Finally, Corient Private Wealth LLC boosted its stake in PACS Group by 29.7% in the fourth quarter. Corient Private Wealth LLC now owns 170,052 shares of the company's stock worth $6,528,000 after buying an additional 38,956 shares in the last quarter.

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company's operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.